XML 60 R41.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule Of Shares Of Common Stock Reserved For Future Issuance
The Company has the following common stock reserved for future issuance:
December 31, 2022
Outstanding options25,988,465 
Outstanding RSUs7,469,000 
Shares reserved under 2021 Plan5,492,262 
Total38,949,727 
Share-Based Payment Arrangement, Activity
A summary of the Company's stock option activity with respect to options granted under the Plans is as follows:

Number of Options
Weighted
Average exercise price
Weighted remaining contractual term (years)Aggregate
Intrinsic
Value








Outstanding as of January 1, 2022

32,702,963$3.98 8.34$38,894 


Granted

— $— 
Exercised

(4,393,437)$0.66 $5,272 
Forfeited

(2,321,061)$3.71 
Outstanding as of December 31, 2022

25,988,465$4.56 7.75$6,285 


Exercisable options at end of the year

16,618,550$2.29 7.57$6,230 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The fair value of each service-based award is estimated on the date of grant using the Black-Scholes model that uses the assumptions noted in the following table:
20212020
Expected volatility62%50%
Risk-free interest rate
1.31% - 1.34%
0.4% - 0.8%
Dividend yield—%—%
Expected life5.815.83

These assumptions and estimates were determined as follows:
Share-Based Payment Arrangement, Restricted Stock Unit, Activity
The following table summarizes the RSU activity for the year ended December 31, 2022:


RSUs
Outstanding

Weighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 2021

4,924,417$4.38
RSUs granted

7,052,593$1.92
RSUs vested

(2,632,633)$3.20
RSUs forfeited

(1,875,377)$3.43
Unvested and Outstanding as of December 31, 2022

7,469,000$2.72
Share-Based Payment Arrangement, Cost by Plan
The stock-based compensation expense by line item in the accompanying consolidated statement of operations is summarized as follows:

Year Ended December 31,
202220212020
Cost of revenue$1,376 $877 $335 
Research and development4,268 2,798 1,251 
Sales and marketing3,711 2,173 1,639 
General and administrative14,290 11,217 1,889 
Total expenses$23,645 $17,065 $5,114